ACN
45
-2
LEN
48
3
CAT
62
-10
LOW
45
2
FE
37
2
RSG
45
-2
VRSN
58
-2
EXPD
39
2
ABT
47
2
PNR
65
3
GOOG
65
2
GIS
43
2
C
71
-6
CF
63
-2
WEC
51
3
DUK
49
4
KIM
60
3
DE
62
4
STX
73
3
FOXA
63
4
ACN
45
-2
LEN
48
3
CAT
62
-10
LOW
45
2
FE
37
2
RSG
45
-2
VRSN
58
-2
EXPD
39
2
ABT
47
2
PNR
65
3
GOOG
65
2
GIS
43
2
C
71
-6
CF
63
-2
WEC
51
3
DUK
49
4
KIM
60
3
DE
62
4
STX
73
3
FOXA
63
4
Financhill
Back

Aytu BioPharma Vs. Akero Therapeutics Industry Stock Comparison

Sell
50

AYTU
Aytu BioPharma

Last Price:
$2.18
Seasonality Move:
19.51%
Sell
46

AKRO
Akero Therapeutics

Last Price:
$51.57
Seasonality Move:
49.94%
Sell
50
Aytu BioPharma (AYTU) is a Sell

Is Aytu BioPharma a Buy, Sell or Hold?

  • The current Aytu BioPharma [AYTU] share price is $2.29. The Score for AYTU is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • AYTU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $52.00. The Score for AKRO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AYTU Stock Price Chart

What is Aytu BioPharma's stock price today?

  • The Aytu BioPharma share price today is $2.29
    The current trend is moderately bullish and AYTU is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $52.00
    The current trend is moderately bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

AYTU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 62.73 Buy
Chaikin Money Flow: -76089 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.85 - 2.29) Buy
Bollinger Bands (100): (1.08 - 1.96) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.45 Buy
Relative Strength Index (14 RSI): 50.77 Buy
Chaikin Money Flow: 725125 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (52.02 - 55.32) Sell
Bollinger Bands (100): (40.13 - 51.95) Buy

AYTU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.31 Sell
20-day SMA: 2.13 Buy
50-day SMA: 1.85 Buy
200-day SMA: 1.67 Buy
8-day EMA: 2.29 Buy
20-day EMA: 2.15 Buy
50-day EMA: 1.9 Buy
200-day EMA: 1.82 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 51.68 Buy
20-day SMA: 53.56 Sell
50-day SMA: 49.03 Buy
200-day SMA: 39.09 Buy
8-day EMA: 52 Buy
20-day EMA: 52.31 Sell
50-day EMA: 49.71 Buy
200-day EMA: 40.88 Buy

Aytu BioPharma Earnings Growth & AYTU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, an increase next quarter of $0.07 per share, an increase this year of $0.93 per share, and a decrease next year of $1.47 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.64 per share.

Aytu BioPharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):